Bioactivity | CYB210010 is an orally bioavailable, long-acting serotonin 5-HT2 receptor agonist that selectively targets 5-HT2A and 5-HT2C receptors (EC50: 4.1 n, 7.3 nM). CYB210010 can enter the central nervous system, cause a head twitch response (HTR), and is not prone to behavioral tolerance during chronic administration[1]. |
In Vivo | CYB210010 具有一定的口服生物利用度,可顺利进入中枢神经系统,与额叶皮层 5-HT2A 受体结合,并增加额叶皮层神经可塑性相关基因的表达[1]。CYB210010 (0.1-3 mg/kg; sc; 单剂量) 会引起小鼠的头部抽搐反应 (HTR),并且可以以阈值剂量亚慢性给药,而不会产生行为耐受性[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: |
CAS | 2762568-47-6 |
Formula | C11H15ClF3NO2S |
Molar Mass | 317.76 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Varty GB, et al. Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT2 Receptor Agonist. J Med Chem. 2024 Apr 25;67(8):6144-6188. |